Best Grants for Capital Funding in Nebraska

May Family Foundation

Eleanor Jean May established the May Family Foundation in 2000, as a gesture of gratitude to the communities that shaped her life. The May Family Foundation is dedicated to identifying programs that strongly resonate with our mission and values as we work together to empower and uplift lives within our communities.

Our foundation provides resources and opportunities that empower young individuals to thrive and reach their full potential. Our goal is to create a brighter future for under-resourced youth in our local communities.

May Family Foundation After-School Enrichment Grant

Our foundation strives to be engaged in our local communities beyond grant funding. We support select programs that align with our goals and form a connection through potential volunteering opportunities, site visits, and recognition of successes.

We welcome grant applications for financial support in after-school enrichment:

• Programs with trained instructors that provide students with opportunities to participate in enrichment activities to learn new things and develop skills they will find useful in real life.

The Mina Larson and Mandas S. Mulrain Scholarship, established in 2005 by Mr. Sam Mulrain, honors the legacy of his wife, Mina Larson Mulrain. This scholarship aims to support high school seniors from southern Beaufort County who exhibit exceptional determination in their academic pursuits. With a focus on financial need and a minimum GPA of 3.0, it empowers deserving students to achieve their post-secondary educational goals, fostering leadership and community engagement.

Founded in 2016, this program supports nonfiction filmmakers or filmmaking teams working on their first or second feature-length documentary.

In this year-long program, 9 filmmakers will receive:

• $40,000 USD in grant funding for the production of their feature-length film
• Mentorship with Chicken & Egg Films team members
• Two creative retreats focused on career building and creative development
• Travel stipend for director and producer upon acceptance to a forum or market during program year
• Tailored industry meetings and funder connections
• Peer support from their cohort

You do not need a fiscal sponsor to apply for the (Egg)celerator Lab. However, if you are selected for the Lab, you must secure a US fiscal sponsor, or be a 501(c)(3), to receive the funds. If granted, we can help advise on finding a fiscal sponsor. 

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.

The DTA Foundation: Dental Scholarship aims to support dental students halfway through their education who show a commitment to community service. With over 20 years of experience in enhancing oral care, the foundation, backed by generous donations, empowers the next generation of dental professionals. In honor of Robert J. Sullivan, $125,000 was established to improve dental education across the U.S., with scholarships awarded to deserving students who embody the foundation's mission.

The J&B Family Scholarship Fund, managed by the San Antonio Area Foundation, supports students pursuing degrees in Science, Engineering, Technology, or Math. Eligible applicants include high school seniors and current college students under 40 with a minimum 3.0 GPA from Bexar County. The scholarship offers funding for tuition and other educational expenses for one student annually, fostering educational advancement and community development. This renewable scholarship can greatly assist those demonstrating financial need.

The Jim and Marge Krum Foundation Scholarship, established in 2003, aims to support outstanding high school seniors from Hilton Head Island and Bluffton who demonstrate academic excellence and significant community service. Funded by the Community Foundation of the Lowcountry, this scholarship fosters a lifelong commitment to community leadership among recipients, ensuring they remain connected through their shared dedication to service. Applicants must have a minimum GPA of 3.25 and be accepted into an accredited college or university.

The Warren L. and Florence W. Calvert Memorial Scholarship Fund, established in 1974, supports deserving geological students pursuing graduate studies in Economic Geology. Awarded first in 1978, the fund is sustained by contributions from HGS members and investment returns. Recipients, selected based on academic merit and endorsements from Earth Science professionals, must carry a minimum of 9 credit hours and can renew for subsequent years with satisfactory progress.

The TidePointe Community Educational Scholarship, established by the residents of TidePointe, supports employees and their dependents pursuing secondary or post-secondary education. This initiative reflects the community's generosity and commitment to academic achievement. Eligible applicants must be U.S. citizens or legal residents, work at least 12 hours a week at TidePointe, and have maintained good employment records. This scholarship empowers individuals to achieve their educational ambitions, fostering growth and opportunity within the Lowcountry community.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Acute Myeloid Leukemia (AML) Fund

Help with healthcare costs for acute myeloid leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Chronic Lymphocytic Leukemia (CLL) Fund

Help with healthcare costs for chronic lymphocytic leukemia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See Approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The SOT Science Policy Leadership Award honors elected officials who advocate for scientific research that protects health and the environment. By recognizing individuals who support public policy that advances safety for people and animals, this award promotes the importance of science in decision-making processes. The Society of Toxicology aims to highlight the contributions of leaders in science policy, encouraging further advancements in health and safety research while fostering a collaborative relationship between science and government.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Fund

Help with healthcare costs for hemophilia

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Ida V. Holland Educational Scholarship, offered by the San Antonio Area Foundation, supports full-time students pursuing various degrees. Eligible candidates must be Bexar County residents facing financial challenges. The scholarship, renewable for up to three years, aims to assist parentless or low-income students, ensuring they receive the necessary educational funding to thrive. Since its inception in 1964, the foundation has significantly impacted the community through grants and scholarships.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Hemophilia Health Equity Fund

Help with healthcare costs for hemophilia (health equity fund)

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Health Equity Funds offer help to eligible patients living in areas identified as having increased social and financial needs, as well as higher rates of chronic conditions. Eligibility is determined in part by home address zip code. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The RAE Family Community Scholarship, established by the Tulsa Community Foundation, supports high school graduates from Mayes County, Oklahoma, seeking to enroll in undergraduate programs. Since its inception in 1998, the Tulsa Community Foundation has been dedicated to enhancing the community through charitable efforts and grants, ensuring that all individuals and families can thrive. This scholarship is a vital resource for students aiming to further their education and make a positive impact in their communities.

The Grossman-Sada Scholarship Fund, managed by the San Antonio Area Foundation, supports full-time college students engaged in international exchange programs between Mexico and the U.S. This scholarship covers the cost of attendance for students pursuing a Bachelor's degree in any field. Since 1964, the foundation has played a vital role in enhancing community life through various grants and scholarships, emphasizing meaningful contributions for future generations.

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type III (MPS III) Fund

Help with healthcare costs for mucopolysaccharidosis type III

This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. 

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

Patient Advocate Foundation

Patient Advocate Foundation is the nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford the care they need—while improving the healthcare system for all.

Patient Advocate Foundation provides financial assistance to help patients afford treatment and cost of living needs, personalized case management to navigate complex healthcare and social needs challenges, and a wide array of resources to empower people to take charge of their health. Since our founding in 1996—and joining forces with the PAN Foundation in 2026—we have helped 3.8 million patients navigate and access care, granted over $7 billion in financial assistance, served 350,000 people through personalized case management and elevated the patient’s voice to drive improvements in the healthcare system.

Mucopolysaccharidosis Type VII (MPS VII) Fund

Help with healthcare costs for mucopolysaccharidosis type VII

This TotalAssist Health Equity Fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses.

Approved medications

Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines. See approved medication list for this condition.

Patient Advocate Foundation verifies your diagnosis and treatment plan with your provider directly. We also automatically verify the income eligibility for every applicant. 

The Rural Health Network Development Planning Program aims to enhance rural health care by fostering integrated health care networks. It focuses on collaboration among entities to bolster local capacity and improve care coordination in underserved areas. By achieving efficiencies and expanding access to essential services, the program seeks to strengthen the overall rural health system while promoting the use of health information technology and exploring innovative care delivery models.

The McKernon Scholarship, offered by the St. Croix Valley Foundation, supports financial need-based students from Pierce County, particularly targeting graduates of Elmwood High School and non-traditional learners pursuing their first degree. The Foundation, a prominent philanthropic organization, aims to foster local impact through generous donations, having facilitated over $100 million in grants since its establishment in 1995. This scholarship embodies their mission to enhance community prosperity and empower individuals through education.

The Permobil Foundation offers sponsorships and grants to enhance the lives of individuals with mobility limitations. Committed to promoting independent mobility as a basic human right, the Foundation supports organizations that align with its mission through event sponsorships, grant funding, employee engagement, and in-kind donations. Applications are accepted monthly, with an emphasis on initiatives that yield significant community impact. The Foundation prioritizes relationships with Permobil employees and critical community needs.

The RNomics Technology Enhancement Centers, supported by the NIH Common Fund, aim to enhance tools for comprehensive RNA analysis, facilitating insights into health and disease. This initiative focuses on developing technologies for RNA sequencing, modification mapping, and functional testing. By fostering collaborations and strengthening existing resources, RTECs will advance the study of RNA molecules, ensuring broad community access to improved experimental and computational methods.

The RNomics Outreach and Coordination (ROC) Center, established by the NIH Common Fund, aims to enhance understanding of RNA molecules through integrated analysis. This center will serve as a hub for data management and community engagement, developing a central data portal, supporting data standards, and coordinating consortium-wide analyses. By fostering collaborations and providing training, the ROC Center seeks to ensure the long-term availability of essential RNomics resources, ultimately advancing health and disease research.

The Robinson Crowell & Rotary Club of Sacramento Foundation Annual Scholarships support local high school seniors from C.K. McClatchy, Sacramento Charter, and West Campus High Schools. Each school awards two scholarships, with amounts of $2500 and $1750, respectively. These scholarships promote higher education and embody the Rotary spirit of service. Candidates must be academically strong and committed to full-time undergraduate studies, while ensuring no familial ties to Rotarians.

The Transfer Pathways to the Liberal Arts Grant Program, sponsored by the Teagle Foundation and Arthur Vining Davis Foundations, aims to enhance transfer opportunities between community colleges and private four-year liberal arts institutions. With grants up to $350,000, this initiative supports partnerships that promote timely degree completion for underrepresented students, fostering diversity and enriching academic environments. The program addresses transfer challenges, ensuring alignment in curricula and maximizing credit transferability to facilitate successful transitions to higher education.

The RNomics Molecular Standards initiative, supported by the NIH Common Fund, aims to enhance research on RNA molecules by developing standardized references. This program will facilitate the creation, testing, and distribution of RNA molecular reference standards, which are crucial for ensuring consistency and reliability in RNA research. By providing guidance on best practices and planning for long-term availability, RNomics will help advance technologies that analyze RNA sequences and functions, ultimately improving health and disease understanding.